In this large, national retrospective cohort of 20 822 youth aged 13 to 25 years with opioid use disorder, medication receipt increased from 2001 to 2014, but only 1 in 4 individuals received buprenorphine or naltrexone. Younger individuals, females, and black and Hispanic youth were less likely to receive a medication.
